Description / Application
Daclatasvir is a member of the class of biphenyls that is a potent inhibitor of nonstructural protein 5A and is used (as its hydrochloride salt) for treatment of hepatitis C. It has a role as an antiviral drug and a nonstructural protein 5A inhibitor. It is a member of biphenyls, a carbamate ester, a member of imidazoles, a valine derivative and a carboxamide. It is a conjugate base of a daclatasvir(2+).
Identities
| Alternative Name | BMS-790052 |
|---|---|
| Molecular Formula | C40H50N8O6 |
| Molecular Weight | 738.9 |
| MFCD | MFCD17129086 |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315;H319;H335 |
| Precautionary Statements | P261;P264;P271;P280;P302+P352;P304+P340;P305+P351+P338;P312;P321;P332+P313;P337+P313;P362;P403+P233;P405;P501 |